Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576575 · ClinicalTrials.gov registry record · NA
Buprenorphine Disposition and CYP3A
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01576575 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 21 participants.
The verdict
NCT01576575, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To evaluate role of CYP3A in buprenorphine disposition and effect
Interventions
- DRUG Buprenorphine Control
- DRUG Buprenorphine + Rifampin
- DRUG Buprenorphine + Grapefruit juice
- DRUG Buprenorphine + Ketoconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-03-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576575
The ClinicalTrials.gov registry entry for NCT01576575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Buprenorphine Control is the first listed.
NCT01576575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01576575 about?
NCT01576575 is a clinical study titled "Buprenorphine Disposition and CYP3A". To evaluate role of CYP3A in buprenorphine disposition and effect
What is the current status of trial NCT01576575?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2010-06. Estimated completion is 2014-03-29.
What interventions are being tested in trial NCT01576575?
The interventions under investigation include: Buprenorphine Control (DRUG), Buprenorphine + Rifampin (DRUG), Buprenorphine + Grapefruit juice (DRUG), Buprenorphine + Ketoconazole (DRUG).
Who is sponsoring clinical trial NCT01576575?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.